German Pharma Deal: Biontech to Acquire Competitor Curevac
Quelle: STUTTGARTER ZEITUNG UND STUTTGARTER NACHRICHTEN (Glomex)
Once both were considered major biotech hopefuls, they were in a neck-and-neck race for the COVID-19 vaccine, fighting over patents. Now, Biontech from Mainz is reaching for Curevac from Tübingen.